 Brenton Rose
|
|
| Title | Assistant Clinical Professor |
|---|
| Institution | University of California San Diego |
|---|
| Department | Radiation Medicine and Applied Science |
|---|
| Address | 9500 Gilman Drive #0861
La Jolla CA 92093
|
|---|
| Phone | 858-246-2418 |
|---|
| vCard | Download vCard |
|---|
|
|
 ORNG Applications Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Researchers can login to make corrections and additions, or contact us for help.
-
Bryant AK, D'Amico AV, Nguyen PL, Einck JP, Kane CJ, McKay RR, Simpson DR, Mundt AJ, Murphy JD, Rose B. Three-month posttreatment prostate-specific antigen level as a biomarker of treatment response in patients with intermediate-risk or high-risk prostate cancer treated with androgen deprivation therapy and radiotherapy. Cancer. 2018 May 04. PMID: 29727915.
-
Bryant AK, Kader AK, McKay RR, Einck JP, Mell LK, Mundt AJ, Kane CJ, Efstathiou JA, Murphy JD, Rose B. Definitive Radiation Therapy and Survival in Clinically Node-Positive Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018 Apr 17. PMID: 29891203.
-
Nath SK, Rose B, Pugh TJ. Who benefits most from early salvage radiation therapy after prostatectomy? Transl Androl Urol. 2018 Mar; 7(Suppl 1):S124-S127. PMID: 29644179.
-
Hopper AB, Sandhu APS, Parsons JK, Rose B, Einck JP. Salvage image guided radiation therapy to the prostate after cryotherapy failure. Adv Radiat Oncol. 2018 Jan-Mar; 3(1):52-56. PMID: 29556580.
-
Rose B, Mitra D, Hong TS, Jee KW, Niemierko A, Drapek LN, Blaszkowsky LS, Allen JN, Murphy JE, Clark JW, Ryan DP, Wo JY. Irradiation of anatomically defined pelvic subsites and acute hematologic toxicity in anal cancer patients undergoing chemoradiation. Pract Radiat Oncol. 2017 Sep - Oct; 7(5):e291-e297. PMID: 28462895.
-
Rose B, Winer EP, Mamon HJ. Reply to S. Sorscher. J Clin Oncol. 2017 May 20; 35(15):1746-1747. PMID: 28524778.
-
Mitra D, Hong TS, Horick N, Rose B, Drapek LN, Blaszkowsky LS, Allen JN, Kwak EL, Murphy JE, Clark JW, Ryan DP, Cusack JC, Bordeianou LG, Berger DL, Wo JY. Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529. Adv Radiat Oncol. 2017 Apr-Jun; 2(2):110-117. PMID: 28740921.
-
Rose B, Winer EP, Mamon HJ. Perils of the Pathologic Complete Response. J Clin Oncol. 2016 Nov 20; 34(33):3959-3962. PMID: 27551115.
-
Muralidhar V, Mahal BA, Rose B, Chen YW, Nezolosky MD, Efstathiou JA, Beard CJ, Martin NE, Orio PF, Trinh QD, Choueiri TK, Sweeney CJ, Nguyen PL. Disparities in the Receipt of Local Treatment of Node-positive Prostate Cancer. Clin Genitourin Cancer. 2017 Oct; 15(5):563-569.e3. PMID: 28462857.
-
Rose B, Chen MH, Wu J, Braccioforte MH, Moran BJ, Doseretz DE, Katin MJ, Ross RH, Salenius SA, D'Amico AV. Androgen Deprivation Therapy Use in the Setting of High-dose Radiation Therapy and the Risk of Prostate Cancer-Specific Mortality Stratified by the Extent of Competing Mortality. Int J Radiat Oncol Biol Phys. 2016 11 15; 96(4):778-784. PMID: 27788950.
-
Muralidhar V, Rose B, Chen YW, Nezolosky MD, Nguyen PL. Association Between Travel Distance and Choice of Treatment for Prostate Cancer: Does Geography Reduce Patient Choice? Int J Radiat Oncol Biol Phys. 2016 10 01; 96(2):313-317. PMID: 27496390.
-
Carmona R, Zakeri K, Green G, Hwang L, Gulaya S, Xu B, Verma R, Williamson CW, Triplett DP, Rose B, Shen H, Vaida F, Murphy JD, Mell LK. Improved Method to Stratify Elderly Patients With Cancer at Risk for Competing Events. J Clin Oncol. 2016 Apr 10; 34(11):1270-7. PMID: 26884579.
-
Rose B, Jee KW, Niemierko A, Murphy JE, Blaszkowsky LS, Allen JN, Lee LK, Wang Y, Drapek LC, Hong TS, Wo JY. Irradiation of FDG-PET-Defined Active Bone Marrow Subregions and Acute Hematologic Toxicity in Anal Cancer Patients Undergoing Chemoradiation. Int J Radiat Oncol Biol Phys. 2016 Mar 15; 94(4):747-54. PMID: 26972647.
-
Rose B, Jiang W, Punglia RS. Effect of lymph node metastasis size on breast cancer-specific and overall survival in women with node-positive breast cancer. Breast Cancer Res Treat. 2015 Jul; 152(1):209-216. PMID: 26041688.
-
Zakeri K, Rose B, D'Amico AV, Jeong JH, Mell LK. Competing events and costs of clinical trials: Analysis of a randomized trial in prostate cancer. Radiother Oncol. 2015 Apr; 115(1):114-9. PMID: 25857696.
-
Viswanathan AN, Lee LJ, Eswara JR, Horowitz NS, Konstantinopoulos PA, Mirabeau-Beale KL, Rose B, von Keudell AG, Wo JY. Complications of pelvic radiation in patients treated for gynecologic malignancies. Cancer. 2014 Dec 15; 120(24):3870-83. PMID: 25056522.
-
Carmona R, Gulaya S, Murphy JD, Rose B, Wu J, Noticewala S, McHale MT, Yashar CM, Vaida F, Mell LK. Validated competing event model for the stage I-II endometrial cancer population. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):888-98. PMID: 24969798.
-
Rose B, Chen MH, Zhang D, Hirsch MS, Richie JP, Chang SL, Hegde JV, Loffredo MJ, D'Amico AV. Maximum tumor diameter and the risk of prostate-specific antigen recurrence after radical prostatectomy. Clin Genitourin Cancer. 2014 Oct; 12(5):e173-9. PMID: 24787967.
-
Mell LK, Zakeri K, Rose B. On lumping, splitting, and the nosology of clinical trial populations and end points. J Clin Oncol. 2014 Apr 01; 32(10):1089-90. PMID: 24550413.
-
Pan H, Rose B, Simpson DR, Mell LK, Mundt AJ, Lawson JD. Clinical practice patterns of lung stereotactic body radiation therapy in the United States: a secondary analysis. Am J Clin Oncol. 2013 Jun; 36(3):269-72. PMID: 22495454; PMCID: PMC3396796.
-
Waters JD, Rose B, Gonda DD, Scanderbeg DJ, Russell M, Alksne JF, Murphy K, Carter BS, Lawson J, Chen CC. Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastoma. J Neurooncol. 2013 Jul; 113(3):467-77. PMID: 23673513.
-
Jensen LG, Hasselle MD, Rose B, Nath SK, Hasan Y, Scanderbeg DJ, Yashar CM, Mundt AJ, Mell LK. Outcomes for patients with cervical cancer treated with extended-field intensity-modulated radiation therapy and concurrent cisplatin. Int J Gynecol Cancer. 2013 Jan; 23(1):119-25. PMID: 23262521.
-
Zakeri K, Rose B, Gulaya S, D'Amico AV, Mell LK. Competing event risk stratification may improve the design and efficiency of clinical trials: secondary analysis of SWOG 8794. Contemp Clin Trials. 2013 Jan; 34(1):74-9. PMID: 23063467; PMCID: PMC3525784.
-
Liang Y, Bydder M, Yashar CM, Rose B, Cornell M, Hoh CK, Lawson JD, Einck J, Saenz C, Fanta P, Mundt AJ, Bydder GM, Mell LK. Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):406-14. PMID: 22687195.
-
Mell LK, Lau SK, Rose B, Jeong JH. Reporting of cause-specific treatment effects in cancer clinical trials with competing risks: a systematic review. Contemp Clin Trials. 2012 Sep; 33(5):920-4. PMID: 22664646.
-
Simpson DR, Song WY, Moiseenko V, Rose B, Yashar CM, Mundt AJ, Mell LK. Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin. Int J Radiat Oncol Biol Phys. 2012 May 01; 83(1):e81-6. PMID: 22516388.
-
Rose B, Liang Y, Lau SK, Jensen LG, Yashar CM, Hoh CK, Mell LK. Correlation between radiation dose to ¹8F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):1185-91. PMID: 22270171.
-
Rose B, Jeong JH, Nath SK, Lu SM, Mell LK. Population-based study of competing mortality in head and neck cancer. J Clin Oncol. 2011 Sep 10; 29(26):3503-9. PMID: 21844503.
-
Nath SK, Carmona R, Rose B, Simpson DR, Russell M, Lawson JD, Mundt AJ, Murphy KT. Observed magnetic resonance imaging changes in pediatric patients treated with stereotactic radiosurgery for intracranial tumors. Childs Nerv Syst. 2011 Mar; 27(3):399-406. PMID: 20927529; PMCID: PMC3042094.
-
Simpson DR, Lawson JD, Nath SK, Rose B, Mundt AJ, Mell LK. A survey of image-guided radiation therapy use in the United States. Cancer. 2010 Aug 15; 116(16):3953-60. PMID: 20564090; PMCID: PMC2919592.
-
Hasselle MD, Rose B, Kochanski JD, Nath SK, Bafana R, Yashar CM, Hasan Y, Roeske JC, Mundt AJ, Mell LK. Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2011 Aug 01; 80(5):1436-45. PMID: 20708346.
-
Liang Y, Messer K, Rose B, Lewis JH, Jiang SB, Yashar CM, Mundt AJ, Mell LK. Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: principal component analysis on high dimensional data. Int J Radiat Oncol Biol Phys. 2010 Nov 01; 78(3):912-9. PMID: 20472344; PMCID: PMC2923677.
-
Rose B, Aydogan B, Liang Y, Yeginer M, Hasselle MD, Dandekar V, Bafana R, Yashar CM, Mundt AJ, Roeske JC, Mell LK. Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2011 Mar 01; 79(3):800-7. PMID: 20400238; PMCID: PMC2907446.
-
Simpson DR, Lawson JD, Nath SK, Rose B, Mundt AJ, Mell LK. Utilization of advanced imaging technologies for target delineation in radiation oncology. J Am Coll Radiol. 2009 Dec; 6(12):876-83. PMID: 19945044.
-
Nath SK, Sandhu AP, Rose B, Simpson DR, Nobiensky PD, Wang JZ, Millard F, Kane CJ, Parsons JK, Mundt AJ. Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010 Oct 01; 78(2):435-41. PMID: 19939580.
-
Nath SK, Simpson DR, Rose B, Sandhu AP. Recent advances in image-guided radiotherapy for head and neck carcinoma. J Oncol. 2009; 2009:752135. PMID: 19644564; PMCID: PMC2717698.
|
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Related Authors People who share related concepts with this person. _
|